The effect of SGLT2 inhibition on prostate cancer Mendelian randomization and observational analysis using electronic healthcare and cohort data

被引:1
|
作者
Zheng, Jie [1 ,2 ,3 ]
Lu, Jieli [1 ,2 ]
Qi, Jiying [1 ,2 ]
Yang, Qian [3 ]
Zhao, Huiling [3 ]
Liu, Haoyu [1 ,2 ]
Chen, Zhihe [1 ,2 ]
Huang, Lanhui [1 ,2 ]
Ye, Youqiong [4 ,5 ]
Xu, Min [1 ,2 ]
Xu, Yu [1 ,2 ]
Wang, Tiange [1 ,2 ]
Li, Mian [1 ,2 ]
Zhao, Zhiyun [1 ,2 ]
Zheng, Ruizhi [1 ,2 ]
Wang, Shuangyuan [1 ,2 ]
Lin, Hong [1 ,2 ]
Hu, Chunyan [1 ,2 ]
Chui, Celine Sze Ling [6 ,7 ,8 ]
Yeung, Shiu Lun Au [7 ]
Luo, Shan [3 ,7 ]
Dimopoulou, Olympia [3 ,9 ]
Dixon, Padraig [3 ,10 ]
Harrison, Sean [3 ,10 ]
Liu, Yi [3 ]
Robinson, Jamie [3 ]
Yarmolinsky, James [3 ]
Haycock, Philip [3 ]
Yuan, Jinqiu [12 ,13 ,14 ,15 ]
Lewis, Sarah [3 ]
Yuan, Zhongshang [16 ]
Gaunt, Tom R. [3 ,11 ,17 ,18 ]
Smith, George Davey [3 ,11 ,17 ,18 ]
Ning, Guang [1 ,2 ]
Martin, Richard M. [3 ,7 ,17 ,18 ]
Cui, Bin [1 ,2 ]
Wang, Weiqing [1 ,2 ]
Bi, Yufang [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Sch Med, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Natl Clin Res Ctr Metab Dis, Natl Hlth Commiss PR China,Shanghai Digital Med In, Shanghai, Peoples R China
[3] Univ Bristol, Bristol Med Sch, MRC Integrat Epidemiol Unit IEU, Oakfield House, Bristol BS8 2BN, England
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Immunol, Ctr Immune Related Dis,Sch Med, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Immunol & Microbiol, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200025, Peoples R China
[6] Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Hong Kong, Peoples R China
[7] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China
[8] Lab Data Discovery Hlth D24H, Hong Kong Sci Pk,Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China
[9] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol BS8 2PS, England
[10] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England
[11] Univ Bristol, Bristol Med Sch, Dept Populat Hlth Sci, Bristol BS8 2BN, England
[12] Sun Yat sen Univ, Affiliated Hosp 7, Clin Res Ctr, Shenzhen 518107, Guangdong, Peoples R China
[13] Sun Yat sen Univ, Affiliated Hosp 7, Ctr Digest Dis, Shenzhen 518107, Guangdong, Peoples R China
[14] Guangzhou Women & Children Med Ctr, Guangzhou 510623, Guangdong, Peoples R China
[15] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Peoples R China
[16] Shandong Univ, Cheeloo Coll Med, Sch Publ Hlth, Dept Biostat, Jinan, Peoples R China
[17] Univ Hosp Bristol & Weston NHS Fdn Trust, NIHR Biomed Res Ctr, Bristol, England
[18] Univ Bristol, Bristol, England
基金
中国国家自然科学基金; 英国医学研究理事会; 英国惠康基金;
关键词
RISK; EPIDEMIOLOGY; ASSOCIATION; INSTRUMENTS; MEDICATION; UPDATE; ADULTS;
D O I
10.1016/j.xcrm.2024.101688
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We evaluated the effect of sodium-glucose cotransporter 2 (SGLT2) inhibition on prostate cancer by evidence triangulation. Using Mendelian randomization, we found that genetically proxied SGLT2 inhibition reduced the risk of overall (odds ratio = 0.56, 95% confidence interval [CI] = 0.38 to 0.82; 79,148 prostate cancer cases and 61,106 controls), advanced, and early-onset prostate cancer. Using electronic healthcare data ( n SGLT2i = 24,155; n DPP4i = 24,155), we found that the use of SGLT2 inhibitors was associated with a 23% reduced risk of prostate cancer (hazard ratio = 0.77, 95% CI = 0.61 to 0.99) in men with diabetes. Using data from two prospective cohorts ( n 4C = 57,779; n UK_Biobank = 165,430), we found little evidence to support the association of HbA1c 1c with prostate cancer, implying a non-glycemic effect of SGLT2 inhibition on prostate cancer. In summary, this study provides multiple layers of evidence to support the beneficial effect of SGLT2 inhibition on reducing prostate cancer risk. Future trials are warranted to investigate whether SGLT2 inhibitors can be recommended for prostate cancer prevention.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Using Genetic Variants to Evaluate the Causal Effect of Plasma Phospholipid Fatty Acids on Breast Cancer and Prostate Cancer: A Mendelian Randomization Study
    Yang, Ze
    Li, Jingjia
    Sun, Yandi
    Qu, Zihao
    Lin, Yindan
    Zhang, Lihong
    He, Qian
    Jia, Xueyao
    Ahmad, Mashaal
    Zhang, Xueyun
    Luo, Yan
    FRONTIERS IN GENETICS, 2021, 12
  • [32] Exploring the Chemopreventive Effect of Medication on Gene Expression Linked to Colorectal Cancer: An Observational and Mendelian Randomization Analysis in Healthy Colon Mucosa
    Moratalla-Navarro, Ferran
    Carreras-Torres, Robert
    Diez-Obrero, Virginia
    Devall, Matthew
    Obon-Santacana, Mireia
    Diez-Villanueva, Anna
    Guino, Elisabet
    Casey, Graham
    Li, Li
    Moreno, Victor
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [33] Exploring the chemopreventive effect of drugs on colorectal cancer associated gene expression in healthy colon mucosa: An observational and Mendelian randomization analysis
    Moratalla-Navarro, Ferran
    Carreras-Torres, Robert
    Diez-Obrero, Virginia
    Obon-Santacana, Mireia
    Devall, Matthew
    Dampier, Christpher
    Guino, Elisabet
    Li, Li
    Casey, Graham
    Moreno, Victor
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 564 - 564
  • [34] Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: a Mendelian Randomization analysis using data from three large cohort studies
    Katharina Nimptsch
    Mingyang Song
    Krasimira Aleksandrova
    Michail Katsoulis
    Heinz Freisling
    Mazda Jenab
    Marc J. Gunter
    Konstantinos K. Tsilidis
    Elisabete Weiderpass
    H. Bas Bueno-De-Mesquita
    Dawn Q. Chong
    Majken K. Jensen
    Chunsen Wu
    Kim Overvad
    Tilman Kühn
    Myrto Barrdahl
    Olle Melander
    Karin Jirström
    Petra H. Peeters
    Sabina Sieri
    Salvatore Panico
    Amanda J. Cross
    Elio Riboli
    Bethany Van Guelpen
    Robin Myte
    José María Huerta
    Miguel Rodriguez-Barranco
    José Ramón Quirós
    Miren Dorronsoro
    Anne Tjønneland
    Anja Olsen
    Ruth Travis
    Marie-Christine Boutron-Ruault
    Franck Carbonnel
    Gianluca Severi
    Catalina Bonet
    Domenico Palli
    Jürgen Janke
    Young-Ae Lee
    Heiner Boeing
    Edward L. Giovannucci
    Shuji Ogino
    Charles S. Fuchs
    Eric Rimm
    Kana Wu
    Andrew T. Chan
    Tobias Pischon
    European Journal of Epidemiology, 2017, 32 : 419 - 430
  • [35] Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: a Mendelian Randomization analysis using data from three large cohort studies
    Nimptsch, Katharina
    Song, Mingyang
    Aleksandrova, Krasimira
    Katsoulis, Michail
    Freisling, Heinz
    Jenab, Mazda
    Gunter, Marc J.
    Tsilidis, Konstantinos K.
    Weiderpass, Elisabete
    Bueno-De-Mesquita, H. Bas
    Chong, Dawn Q.
    Jensen, Majken K.
    Wu, Chunsen
    Overvad, Kim
    Kuehn, Tilman
    Barrdahl, Myrto
    Melander, Olle
    Jirstrom, Karin
    Peeters, Petra H.
    Sieri, Sabina
    Panico, Salvatore
    Cross, Amanda J.
    Riboli, Elio
    Van Guelpen, Bethany
    Myte, Robin
    Maria Huerta, Jose
    Rodriguez-Barranco, Miguel
    Ramon Quiros, Jose
    Dorronsoro, Miren
    Tjonneland, Anne
    Olsen, Anja
    Travis, Ruth
    Boutron-Ruault, Marie-Christine
    Carbonnel, Franck
    Severi, Gianluca
    Bonet, Catalina
    Palli, Domenico
    Janke, Juergen
    Lee, Young-Ae
    Boeing, Heiner
    Giovannucci, Edward L.
    Ogino, Shuji
    Fuchs, Charles S.
    Rimm, Eric
    Wu, Kana
    Chan, Andrew T.
    Pischon, Tobias
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2017, 32 (05) : 419 - 430
  • [36] ALDH2 and head and neck cancer:: A meta-analysis using mendelian randomization approach
    Boccia, S.
    Hashibe, M.
    GallI, P.
    De Feo, E.
    Asakage, T.
    Hashimoto, T.
    Hiraki, A.
    Katoh, T.
    Nomura, T.
    Yokoyama, A.
    van Duijn, C. M.
    Ricciardi, G.
    Boffetta, P.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (11) : S51 - S51
  • [37] Patient and clinical characteristics of heart failure patients concomitantly prescribed SGLT2 inhibitors and sacubitril/valsartan, a database cohort study using the Optum electronic health record data
    Loefroth, E.
    Hughes, M.
    Shi, Y.
    Wang, Y.
    Proudfoot, C.
    Di Domenico, M.
    Modgill, V
    Schlienger, R.
    Studer, R.
    EUROPEAN HEART JOURNAL, 2020, 41 : 981 - 981
  • [38] Association Between Obesity and Chronic Kidney Disease: Multivariable Mendelian Randomization Analysis and Observational Data From a Bariatric Surgery Cohort (vol 72, 496 , 2023)
    Nguyen, Anthony
    Khafagy, Rana
    Gao, Yiding
    Meerasa, Ameena
    Roshandel, Delnaz
    Anvari, Mehran
    Lin, Boxi
    Cherney, David Z. I.
    Farkouh, Michael E.
    Shah, Baiju R.
    Paterson, Andrew D.
    Dash, Satya
    DIABETES, 2023, 72 (08) : 1174 - 1174
  • [39] Impact of SGLT2 inhibitors on survival in gastrointestinal cancer patients undergoing chemotherapy and/or radiotherapy: a real-world data retrospective cohort study
    Flausino, Lucas E.
    Carrasco, Alexis German Murillo
    Furuya, Tatiane Katsue
    Tuan, Wen-Jan
    Chammas, Roger
    BMC CANCER, 2025, 25 (01)
  • [40] Identifying Confounders Using Bayesian Networks and Estimating Treatment Effect in Prostate Cancer With Observational Data
    Sieswerda, Melle
    Xie, Shixuan
    van Rossum, Ruby
    Bermejo, Inigo
    Geleijnse, Gijs
    Aben, Katja
    van Erning, Felice
    Lemmens, Valery
    Dekker, Andre
    Verbeek, Xander
    JCO CLINICAL CANCER INFORMATICS, 2023, 7